Proof-of-concept evidence for lncRNA NRIR downregulation in antiphospholipid syndrome and its obstetric subtype
Clinical innovations in health research-HJM · 06.04.2026 · 3 (1)
DOI: 10.24875/cihr.25000023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical innovations in health research-HJM, online erschienen am 06.04.2026. Verfasst von Carlos A. Guzmán-Martín und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Guzmán-Martín, C. A., Juárez-Vicuña, Y., Martínez-Martínez, L. A., Sánchez-Muñoz, F., & Romero-Nava, R. (2026). Proof-of-concept evidence for lncRNA NRIR downregulation in antiphospholipid syndrome and its obstetric subtype. Clinical innovations in health research-HJM, 3(1). https://doi.org/10.24875/cihr.25000023
Vancouver
Guzmán-Martín CA, Juárez-Vicuña Y, Martínez-Martínez LA, Sánchez-Muñoz F, Romero-Nava R. Proof-of-concept evidence for lncRNA NRIR downregulation in antiphospholipid syndrome and its obstetric subtype. Clinical innovations in health research-HJM. 2026;3(1). doi:10.24875/cihr.25000023
BibTeX
@article{GuzmnMartn2026,
author = {Guzmán-Martín, Carlos A. and Juárez-Vicuña, Yaneli and Martínez-Martínez, Laura A. and Sánchez-Muñoz, Fausto and Romero-Nava, Rodrigo},
title = {Proof-of-concept evidence for lncRNA NRIR downregulation in antiphospholipid syndrome and its obstetric subtype},
journal = {Clinical innovations in health research-HJM},
year = {2026},
volume = {3},
number = {1},
doi = {10.24875/cihr.25000023}
}
EUVIMED